PAVmed Inc [NASDAQ: PAVM] gained 8.69% or 0.03 points to close at $0.36 with a heavy trading volume of 152890 shares.
It opened the trading session at $0.3404, the shares rose to $0.3699 and dropped to $0.3404, the range by which the price of stock traded the whole day. The daily chart for PAVM points out that the company has recorded -41.07% loss over the past six months.
If we look at the average trading volume of 504.40K shares, PAVM reached to a volume of 152890 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about PAVmed Inc [PAVM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PAVM shares is $20.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PAVM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for PAVmed Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 30, 2021. While these analysts kept the previous recommendation, Ascendiant Capital Markets raised their target price to Buy. The new note on the price target was released on November 05, 2020, representing the official price target for PAVmed Inc stock. Previously, the target price had yet another raise to $5, while Maxim Group analysts kept a Buy rating on PAVM stock.
The Price to Book ratio for the last quarter was 0.99, with the Price to Cash per share for the same quarter was set at 0.10.
Trading performance analysis for PAVM stock
PAVmed Inc [PAVM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.18. With this latest performance, PAVM shares dropped by -16.49% in over the last four-week period, additionally sinking by -41.07% over the last 6 months – not to mention a drop of -42.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PAVM stock in for the last two-week period is set at 46.86, with the RSI for the last a single of trading hit 0.0414, and the three-weeks RSI is set at 0.0433 for PAVmed Inc [PAVM]. The present Moving Average for the last 50 days of trading for this stock 0.4209, while it was recorded at 0.3427 for the last single week of trading, and 0.5718 for the last 200 days.
PAVmed Inc [PAVM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and PAVmed Inc [PAVM] shares currently have an operating margin of -69627.59% and a Gross Margin at -1058.62%. PAVmed Inc’s Net Margin is presently recorded at -2051.72%.
PAVmed Inc (PAVM) Capital Structure & Debt Analysis
According to recent financial data for PAVmed Inc. ( PAVM), the Return on Equity (ROE) stands at 20.03%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 9.02%, reflecting the company’s efficiency in generating profits from its assets. Additionally, PAVmed Inc’s Return on Invested Capital (ROIC) is -1.58%, showcasing its effectiveness in deploying capital for earnings.
PAVmed Inc (PAVM) Efficiency & Liquidity Metrics
Based on PAVmed Inc’s (PAVM) latest financial statements, the Debt-to-Equity Ratio is 0.26%, indicating its reliance on debt financing relative to shareholder equity.
PAVmed Inc (PAVM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, PAVmed Inc. (PAVM) effectively leverages its workforce, generating an average of -$15128.21 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.40% and a Quick Ratio of 0.40%, indicating strong ability to cover short-term liabilities.
PAVmed Inc [PAVM]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, PAVmed Inc posted -0.06/share EPS, while the average EPS was predicted by analysts to be reported at -0.4/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.34. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PAVM.
An analysis of Institutional ownership at PAVmed Inc [PAVM]
There are presently around $9.31%, or 11.49%% of PAVM stock, in the hands of institutional investors. The top three institutional holders of PAVM stocks are: FIRST MANHATTAN CO. LLC. with ownership of 0.5 million shares, which is approximately 5.4628%. VANGUARD GROUP INC, holding 0.3 million shares of the stock with an approximate value of $$0.24 million in PAVM stocks shares; and VANGUARD GROUP INC, currently with $$61053.0 in PAVM stock with ownership which is approximately 0.8185%.
